艰难梭菌感染的流行病学变化
Changes in the Epidemiology of Clostridioides difficile Infection.
作者信息
Guh Alice Y, McDonald L Clifford
机构信息
Division of Healthcare Quality Promotion, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H16-3, Atlanta, GA 30333, USA.
Divison of Healthcare Quality Promotion, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS A07, Atlanta, GA 30333, USA.
出版信息
Infect Dis Clin North Am. 2025 Sep 6. doi: 10.1016/j.idc.2025.07.002.
Abstract
This article describes the epidemiology of Clostridioides difficile infection (CDI) by outlining common approaches to CDI surveillance, including the application of a case definition and risk adjustment, and summarizing recent global trends in the incidence or prevalence of CDI. The article also describes important risk factors for CDI and recent advancements in identifying sources of C difficile.
摘要
本文通过概述艰难梭菌感染（CDI）监测的常见方法，包括病例定义的应用和风险调整，以及总结CDI发病率或患病率的近期全球趋势，来描述艰难梭菌感染的流行病学。本文还描述了CDI的重要风险因素以及在确定艰难梭菌来源方面的最新进展。
相似文献
1
Changes in the Epidemiology of Clostridioides difficile Infection.
Infect Dis Clin North Am. 2025 Sep 6. doi: 10.1016/j.idc.2025.07.002.
2
Increase of PCR ribotype 002 infection with decreased disease severity in hospitalized patients in the Netherlands.
Microbiol Spectr. 2025 Aug 19:e0144625. doi: 10.1128/spectrum.01446-25.
3
Regional epidemiologic data call for enhanced attention to Clostridioides difficile infections in Italy: Results from a population-based study.
J Infect Public Health. 2025 Aug 8;18(11):102928. doi: 10.1016/j.jiph.2025.102928.
4
Surveillance and epidemiology of Clostridioides difficile infection using the national health surveillance network criteria: A 7-year study from Mumbai, India.
Indian J Med Microbiol. 2023 Nov-Dec;46:100425. doi: 10.1016/j.ijmmb.2023.100425. Epub 2023 Jul 12.
5
Real-world use of bezlotoxumab to prevent recurrent infections: a single-center experience and meta-analysis.
Therap Adv Gastroenterol. 2025 Jun 21;18:17562848251346593. doi: 10.1177/17562848251346593. eCollection 2025.
6
Global burden and trends of the infection-associated diseases from 1990 to 2021: an observational trend study.
Ann Med. 2025 Dec;57(1):2451762. doi: 10.1080/07853890.2025.2451762. Epub 2025 Jan 23.
7
Risk factors for Clostridioides difficile infection in children: a systematic review and meta-analysis.
J Hosp Infect. 2022 Dec;130:112-121. doi: 10.1016/j.jhin.2022.09.004. Epub 2022 Sep 13.
8
Molecular typing and clinical characteristics of Clostridioides difficile infection in patients with inflammatory bowel disease: A retrospective study.
J Glob Antimicrob Resist. 2025 Jun;43:188-197. doi: 10.1016/j.jgar.2025.04.011. Epub 2025 Apr 24.
9
Omadacycline and : A Systematic Review of Preclinical and Clinical Evidence.
Ann Pharmacother. 2023 Feb;57(2):184-192. doi: 10.1177/10600280221089007. Epub 2022 Jun 3.
10
Antibiotic Use and the Risk of Hospital-Onset Clostridioides Difficile Infection.
JAMA Netw Open. 2025 Aug 1;8(8):e2525252. doi: 10.1001/jamanetworkopen.2025.25252.
本文引用的文献
1
recovered from hospital patients, livestock and dogs in Nigeria share near-identical genome sequences.
Microb Genom. 2025 Jan;11(1). doi: 10.1099/mgen.0.001342.
2
Clostridioides difficile infection and testing rates in South Africa: A multicentre study, 2017-2020.
Anaerobe. 2025 Feb;91:102937. doi: 10.1016/j.anaerobe.2024.102937. Epub 2024 Dec 20.
3
Multicenter study on infections in Mexico: exploring the landscape.
Infect Control Hosp Epidemiol. 2024 Oct 21:1-8. doi: 10.1017/ice.2024.153.
4
The 3 Ds: Depression, Dysbiosis, and Clostridiodes difficile.
Adv Ther. 2024 Nov;41(11):3982-3995. doi: 10.1007/s12325-024-02972-0. Epub 2024 Sep 14.
5
Understanding host immune responses in infection: Implications for pathogenesis and immunotherapy.
Imeta. 2024 May 11;3(3):e200. doi: 10.1002/imt2.200. eCollection 2024 Jun.
6
Defining the phylogenetics and resistome of the major ribotypes circulating in Australia.
Microb Genom. 2024 May;10(5). doi: 10.1099/mgen.0.001232.
7
Incidence of Infections in Republic of Korea: A Prospective Study With Active Surveillance vs. National Data From Health Insurance Review & Assessment Service.
J Korean Med Sci. 2024 Apr 1;39(12):e118. doi: 10.3346/jkms.2024.39.e118.
8
The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence.
J Antimicrob Chemother. 2024 Mar 1;79(3):608-616. doi: 10.1093/jac/dkae012.
9
Comparison of Different Antibiotics and the Risk for Community-Associated Infection: A Case-Control Study.
Open Forum Infect Dis. 2023 Aug 5;10(8):ofad413. doi: 10.1093/ofid/ofad413. eCollection 2023 Aug.
10
Community-associated Clostridioides difficile infection in a general hospital from Argentina.
Anaerobe. 2023 Aug;82:102744. doi: 10.1016/j.anaerobe.2023.102744. Epub 2023 Jun 9.
Zotero 插件